Announcements Trials
Browse Landscape

Status

Completed 4

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 222Observational 4

Sponsor

Cancer Type

CNS 3Thoracic 1

Conditions

Glioblastoma 3Lung Neoplasms 1Glioma 1Astrocytoma 1

Interventions

Sunitinib 16exemestane 11Afatinib 11palbociclib 10Rituximab 10Bevacizumab 10Erlotinib Hydrochloride 9Leuprolide 8Radiotherapy 7Drug Therapy 7Axitinib 7avelumab 6Letrozole 6Capecitabine 6Blood Specimen Collection 6enzalutamide 5Trastuzumab 5Surveys and Questionnaires 5Standard of Care 5Docetaxel 5Aromatase Inhibitors 5lorlatinib 4Specimen Handling 4Radiation 4Mammography 4Crizotinib 4Anastrozole 4Abiraterone Acetate 4temsirolimus 3talazoparib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Has results × Radiation × Clear all
NCT04183218 2026-05-27

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

Mayo Clinic

Completed
24 enrolled 27 charts
Thoracic

Lung Neoplasms

NCT00704808 2015-09-09

Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)

Merck Sharp & Dohme LLC

Completed
180 enrolled 6 charts
CNS

Glioblastoma

NCT00725010 2015-09-09

Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)

Merck Sharp & Dohme LLC

Completed
64 enrolled 7 charts
CNS

Glioblastoma

NCT00723827 2015-01-30

Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)

Merck Sharp & Dohme LLC

Completed
682 enrolled 10 charts
CNS

Astrocytoma, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡